13F

Stock

Ensysce Biosciences, Inc.

ENSC · held by 15 managers

Reported value

$253.5K

Holders

15

+4 new · −7 exited

Holders’ est. mark

−$105.4K

Price effect on 9 books still in the name

Largest holder

$80.6K

ADAGE CAPITAL PARTNERS GP, L.L.C.

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ADAGE CAPITAL PARTNERS GP, L.L.C.149.7K$80.6K−$57.1KCut−$57.1K
PERCEPTIVE ADVISORS LLC86.7K$46.7K−$33.1KCut−$33.1K
GEODE CAPITAL MANAGEMENT, LLC73.9K$39.8K−$8.43KAdded$19.5K
Citadel57.4K$30.9KNew
XTX Topco Ltd24.4K$13.1KNew
VANGUARD FIDUCIARY TRUST CO23.9K$12.9KHeld
JANE STREET GROUP, LLC13.6K$7.31KNew
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC13K$7K−$4.58KCut−$4.04K
VANGUARD CAPITAL MANAGEMENT LLC12.9K$6.93KHeld
UBS Group AG8.79K$4.73K−$38Added$4.64K
Tower Research Capital LLC (TRC)6.09K$3.28K−$2.03KCut−$1.61K
SBI Securities Co., Ltd.486$262−$160Cut−$125
BlackRock, Inc.65$35−$25Cut−$25
Virtu Financial LLC13.3K$7New
FNY Investment Advisers, LLC3K$1−$1Cut−$1

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.